• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.69% Nasdaq Down 1.07%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NasdaqGM
    4.28 Up 0.04(0.94%) Aug 31, 4:00PM EDT
    Add to Portfolio
    Prev Close:4.24
    Open:4.25
    Bid:4.18 x 1000
    Ask:6.75 x 1000
    1y Target Est:5.50
    Beta:3.28379
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:4.23 - 4.43
    52wk Range:2.96 - 9.32
    Volume:328,173
    Avg Vol (3m):529,238
    Market Cap:189.92M
    P/E (ttm):N/A
    EPS (ttm):-0.90
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACRX

    Comparison

    Symbol% ChgMkt Cap
    ACRXUp 0.94%189.92M
    HSPUp 0.04%15.56B
    BAXDown 0.77%20.98B
    CFN 0.00%12.25B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):26.29
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.54
    Quarterly EPS Est (Sep-15) :-0.24
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. The company’s lead product candidate is Zalviso, an investigational, pre-programmed, non-invasive, handhe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback